Non Hodgkin Lymphoma

452 clinical trials · Condition

Record	Firm	Date
Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma (NCT00177554)	University of Pittsburgh	2003-11-01
LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma (NCT00062868)	Baylor College of Medicine	2003-09-01
Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00096161)	Fred Hutchinson Cancer Center	2003-05-01
Stem Cell Transplantation for Patients With Hematologic Malignancies (NCT00152139)	St. Jude Children's Research Hospital	2002-05-01
The Second Multicenter Hemophilia Cohort Study (NCT00341705)	National Cancer Institute (NCI)	2001-04-27
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia (NCT00039910)	Pfizer	2000-07-01
Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016 (NCT03469921)	Institut Paoli-Calmettes	2000-01-01
Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00019708)	National Cancer Institute (NCI)	1999-06-01
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma (NCT00026910)	National Cancer Institute (NCI)	1998-07-01
Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma (NCT00003498)	Burzynski Research Institute	1997-10-13
A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women (NCT00342004)	National Cancer Institute (NCI)	1997-05-01
Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL (NCT00187161)	St. Jude Children's Research Hospital	1994-11-01
Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL) (NCT00100737)	Chiron Corporation
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients (NCT05974410)	AVM Biotechnology Inc

Track Non Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.